What is the catalog number for JNK2 MAPK9 Rabbit Monoclonal Antibody?

The catalog number for JNK2 MAPK9 Rabbit Monoclonal Antibody is orb548089.

What sizes are available for JNK2 MAPK9 Rabbit Monoclonal Antibody?

JNK2 MAPK9 Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is JNK2 MAPK9 Rabbit Monoclonal Antibody in stock?

JNK2 MAPK9 Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

JNK2 MAPK9 Rabbit Monoclonal Antibody

Anti-JNK2 MAPK9 Rabbit Monoclonal Antibody. Tested in WB, IHC, ICC/IF, IP, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat, Monkey.

Product Specifications

Product Name Alternative

Mitogen-activated protein kinase 9; MAP kinase 9; MAPK 9; 2.7.11.24; JNK-55; Stress-activated protein kinase 1a; SAPK1a; Stress-activated protein kinase JNK2; c-Jun N-terminal kinase 2; MAPK9; JNK2, PRKM9, SAPK1A

UniProt

P45984

Reactivity

Human, Monkey, Mouse, Rat

Immunogen

A synthesized peptide derived from human JNK2

Target

Mitogen-activated protein kinase 9

Clonality

Monoclonal

Clone

BGKHX35

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Immunology & Inflammation, Metabolism Research, Protein Biochemistry, Signal Transduction

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:500-2000 IHC 1:50-200 ICC/IF 1:50-200 IP 1:20 FC 1:20

Form

Liquid

Molecular Weight

48 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, ICC, IF, IHC, IP, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.